BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kalambokis GN, Kosta P, Pappas K, Tsianos EV. Haemodynamic and renal effects of tadalafil in patients with cirrhosis. World J Gastroenterol 2010; 16(39): 5009-5010 [PMID: 20954291 DOI: 10.3748/wjg.v16.i39.5009]
URL: https://www.wjgnet.com/1007-9327/full/v16/i39/5009.htm
Number Citing Articles
1
Dmitry Victorovich Garbuzenko. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosisWorld Journal of Gastroenterology 2015; 21(20): 6117-6126 doi: 10.3748/wjg.v21.i20.6117
2
Seong Hee Kang, Moon Young Kim, Soon Koo Baik. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizonHepatology International 2018; 12(S1): 112 doi: 10.1007/s12072-017-9806-1
3
Laurent Savale, Manuel Guimas, Nathan Ebstein, Marie Fertin, Mitja Jevnikar, Sébastien Renard, Delphine Horeau-Langlard, Cécile Tromeur, Céline Chabanne, Grégoire Prevot, Ari Chaouat, Pamela Moceri, Élise Artaud-Macari, Bruno Degano, Romain Tresorier, Clément Boissin, Hélène Bouvaist, Anne-Claire Simon, Marianne Riou, Nicolas Favrolt, Sylvain Palat, Delphine Bourlier, Pascal Magro, Vincent Cottin, Emmanuel Bergot, Nicolas Lamblin, Xavier Jaïs, Audrey Coilly, François Durand, Claire Francoz, Filomena Conti, Philippe Hervé, Gérald Simonneau, David Montani, Jean-Charles Duclos-Vallée, Didier Samuel, Marc Humbert, Pascal De Groote, Olivier Sitbon. Portopulmonary hypertension in the current era of pulmonary hypertension managementJournal of Hepatology 2020; 73(1): 130 doi: 10.1016/j.jhep.2020.02.021
4
Rajeshwar P Mookerjee. Acute-on-chronic liver failure: the liver and portal haemodynamicsCurrent Opinion in Critical Care 2011; 17(2): 170 doi: 10.1097/MCC.0b013e328344a076
5
Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Choudhary, Vijayaraghavan Rajan, Vinod Arora, Ankit Bhardwaj, Guresh Kumar, Manoj Kumar, Shiv K. Sarin. Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trialHepatology International 2023; 17(2): 434 doi: 10.1007/s12072-021-10264-w